Intuitive Surgical, Inc. $ISRG Shares Bought by Consolidated Planning Corp

Consolidated Planning Corp raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,129 shares of the medical equipment provider’s stock after purchasing an additional 338 shares during the quarter. Consolidated Planning Corp’s holdings in Intuitive Surgical were worth $4,961,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in ISRG. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC increased its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on ISRG shares. Royal Bank Of Canada reiterated an “outperform” rating and set a $615.00 price objective on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Truist Financial raised their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Evercore ISI raised their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Finally, Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Intuitive Surgical Stock Down 2.1%

Shares of NASDAQ:ISRG opened at $438.04 on Thursday. The firm has a fifty day moving average of $465.33 and a two-hundred day moving average of $500.54. The firm has a market capitalization of $157.03 billion, a P/E ratio of 61.09, a price-to-earnings-growth ratio of 4.69 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter last year, the business posted $1.78 EPS. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director owned 1,074 shares in the company, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. This represents a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.